Vientiane, Laos - July 14, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that Adagrasibm have been approved by the Ministry of Health of Laos. Approved drugs are: Adagrasib: sold under the brand name ADADX. Adagrasib, a KRAS G12C inhibitor, irreversibly and selectively binds KRAS G12C,…
Vientiane, Laos - May 30, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that Larotrectinib have been approved by the Ministry of Health of Laos. Approved drugs are: Larotrectinib sold under the brand name LARODX. Larotrectinib is an inhibitor of tropomyosin kinase…
June 24, 2024, Haihe Biopharma Co., Ltd. (referred as “Haihe”) announced that Ministry of Health, Labor and Welfare of Japan (厚生労働省) approved New Drug Application (“NDA”) of Gumarontinib (SCC244) for the treatment of unresectable advanced or recurrent non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping mutation. The indication…
Вьентьян, Лаос – 8 апреля 2024 г. – BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что два продукта были одобрены Министерством здравоохранения Лаоса. Разрешенные препараты: Селуметиниб (Selumetinib): продается под торговой маркой SEMEDX. Селуметиниб (Selumetinib) был одобрен для продажи в США 10 апреля…
Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that 2 products have been approved by the Ministry of Health of Laos. Approved drugs are: Selumetinib: sold under the brand name SEMEDX. Selumetinib was approved for…
Introduction If you are looking for new business opportunities in the pharmaceutical industry, there is a product for you: Generic Mitotane sold under the brand name MITODX. BIGBEAR Pharmaceutical: A Beacon of Innovation in Laos BigBear Pharmaceutical is one of the regular chemical pharmaceutical companies in Laos. Accompanied by investors and the…
Vientiane, Laos - April 28, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative therapies for cancer, announced today that it has received approval from the Ministry of Health of Laos for six anti-cancer targeted drugs. The approved drugs are: The approval of these…
El 21 de marzo de 2023, LienTeh anunció una nueva estrategia de contenido destinada a proporcionar información y servicios de longevidad útiles, confiables y centrados en el usuario. Anteriormente, la Red LienTeh se creó originalmente para brindar apoyo durante la pandemia de COVID-19 al promover el equilibrio de atención médica…
On March 21, 2023, LienTeh announced a new content strategy aimed at providing useful, reliable and user-centric longevity information and services. Previously,The LienTeh Network was originally created to provide support during the COVID-19 pandemic by promoting cross-regional healthcare balance and improving access to healthcare resources. After that, the LienTeh network…
Original Brand drug Epclusa （Sofosbuvir/Velpatasvir） is the world’s first all-oral, pan-genotypic, single-tablet hepatitis C treatment regimen, taken orally once daily, for all 6 genotypes (GT-1, -2, -3, -4, -5,-6) Treatment of hepatitis C patients. Currently, there are 26 versions of sofosbuvir/velpatasvir tablets available in the Asia-Pacific region. Generic Drugs Sofosbuvir-velpatasvir Other…
September 16, 2023 (Vientiane) Laos BIGBEAR Pharmaceuticals announced has recently made a significant stride in the field of immune inflammatory disease treatment with the approval of four breakthrough Janus kinase (JAK) inhibitors. The Lao Health Authority has given the green light to TOFADX, RUSODX, UPADX, and DUVACIDX, marking a new…
The Food and Drug Department of the Ministry of Health in Lao PDR is responsible for regulating the registration of pharmaceutical products in the country . They provide a range of forms and guidelines on their website to assist with the registration process . For instance, you can download the…
2 targeted drugs for treatment of the KRAS mutations cancer2 fármacos dirigidos para el tratamiento del cáncer con muta…
BIGBEAR Pharmaceutical announces the approval of Adagrasib i…
BIGBEAR Pharmaceutical announces the approval of Larotrectin…Laos BIGBEAR Pharma’s Advanced JAK Inhibitor Pipeline:…
Copyright © 2021-2022 LienTeh.net All rights reserved.
